The American Diabetes Association guidelines do not list cognitive impairment as a common or expected adverse effect of metformin therapy
When coding adverse drug reactions in the UK, the clinical manifestation should be followed by a Y-code to indicate the medication involved (e.g., Y42.3 for adverse effects of insulin and oral hypoglycaemic drugs)
How Pabau Supports Z79.4 Documentation Most Z79.4 omissions trace back to workflow gaps rather than coding knowledge
Tirzepatide dual receptor mechanism allows it to affect all three simultaneously
The effects of Astragalus membranaceus on repeated restraint stress-induced biochemical and behavioral responses
The primary endpoints for this study were change in body weight and body composition (assessed by dual x-ray absorptiometry [DXA] scanning for total mass, fat mass, and lean mass), and we also assessed food intake, glycated hemoglobin (HbA1c%), and lipid profiles